ST. JOSEPH, Mich., Aug. 15 /PRNewswire/ -- GeneGo, Inc., a leading provider of software and databases for systems biology and pathway analysis announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), has renewed its MetaCore(TM) license from GeneGo to continue a research collaboration with GeneGo on functional analysis of insulin-resistant diabetes in human and animal models. Diabetes, obesity, and other metabolic disorders are priority areas in GeneGo’s effort on annotation of pathways and biological networks involved in common human disorders.
“Diabetes and metabolic diseases in general are of great importance for our pharmaceutical and academic customers, and we do our best to stay on top of current science in this area” says Tatiana Nikolskaya, Chief Scientific Officer and President of GeneGo. “Our collaboration with NIDDK, a leading research institution in metabolic diseases, is a very important part of our development program in this field.”
About GeneGo
GeneGo develops systems biology technology for life science research. The original computational platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, siRNA and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo’s flagship product, MetaCore 4.0, assists pharmaceutical scientists in the areas of target selection and validation, identification of biomarkers for disease states and toxicology. The second product, MetaDrug(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore. For more information, please visit the company’s web site at www.genego.com
MetaCore(TM), MetaBase(TM) and MetaDrug(TM) are trademarks of GeneGo, Inc.
GeneGo, Inc.
CONTACT: Julie Bryant, VP Business Development and Marketing of GeneGo,Inc., +1-858-756 7996, julie@genego.com
Web site: http://www.genego.com//
